Long-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene.
about
Heart failure: advanced development in genetics and epigeneticsDiffuse interstitial fibrosis assessed by cardiac magnetic resonance is associated with dispersion of ventricular repolarization in patients with hypertrophic cardiomyopathy.Electrical defects of the transverse-axial tubular system in cardiac diseasesNovel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathyClinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations.Genetic advances in sarcomeric cardiomyopathies: state of the art.Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy.Allosteric effects of cardiac troponin TNT1 mutations on actomyosin binding: a novel pathogenic mechanism for hypertrophic cardiomyopathy.Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing.Association of genome-wide variation with highly sensitive cardiac troponin-T levels in European Americans and Blacks: a meta-analysis from atherosclerosis risk in communities and cardiovascular health studies.HCM-linked ∆160E cardiac troponin T mutation causes unique progressive structural and molecular ventricular remodeling in transgenic mice.Delineation of Molecular Pathways Involved in Cardiomyopathies Caused by Troponin T MutationsInherited cardiomyopathies caused by troponin mutations.Genetic testing for inherited cardiac disease.Genetic biomarkers in hypertrophic cardiomyopathy.Fatal congenital hypertrophic cardiomyopathy and a pancreatic nodule morphologically identical to focal lesion of congenital hyperinsulinism in an infant with costello syndrome: case report and review of the literature.Linking myofilaments to sudden cardiac death: recent advances.Life-long tailoring of management for patients with hypertrophic cardiomyopathy : Awareness and decision-making in changing scenarios.Risk assessment in hypertrophic cardiomyopathy: contemporary guidelines hampered by insufficient evidence.Molecular mechanisms and structural features of cardiomyopathy-causing troponin T mutants in the tropomyosin overlap region.Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.Distinct ECG Phenotypes Identified in Hypertrophic Cardiomyopathy Using Machine Learning Associate With Arrhythmic Risk Markers.Echocardiographic evaluation of pre-diagnostic development in young relatives genetically predisposed to hypertrophic cardiomyopathy.Interplay Between Sub-Cellular Alterations of Calcium Release and T-Tubular Defects in Cardiac DiseasesThe genetics of hypertrophic cardiomyopathyHypertrophic cardiomyopathy with little hypertrophy and severe arrhythmiaPerspectives on current recommendations for genetic testing in HCM
P2860
Q28080771-883CD708-C93D-4A16-A650-AC5DB8B57B27Q33764571-633C29E3-3B0B-45C0-836B-A0C66E8D1D5EQ33800163-3CB29B30-7D4B-4AB2-814A-ED03F2B0912DQ34445272-E223247B-F31B-4A30-8E49-EB66A82B8310Q34732430-923AD9D1-72BC-4F33-A8FD-0640328A2FA2Q35145962-D05AD26D-9E60-4971-9B38-2156C96FB771Q35880670-C09F0FF0-5BD2-483B-B892-E2C482391A11Q36600756-9EFB55BB-30E4-4FA0-9CAE-0A00EB879ED0Q36712985-05915DD4-C698-4DBB-A1BA-DAD5B2BC43D2Q36957173-36825A9B-BA6C-49AD-B358-F2A7D2AFCD77Q37284441-424FAA4C-7EC6-4558-9426-5FBBC5F98EEAQ37372239-C8BD370B-BD35-4740-AC36-55C70109AB61Q38101039-06AEE09D-C71B-4CED-9029-DA359B54DCB6Q38125385-602F2229-FAE1-4A4A-9D5B-C86A44FB1582Q38125765-C52BD2F9-323C-47FD-909D-884603069CC0Q38350913-1453A409-8FD3-4F89-BE70-891601CBC5C8Q39138183-FC6BFB05-17B0-468B-A3E2-C1B47455E58AQ42320941-2193D9D6-6D44-4607-823C-9C56DDAA4851Q43217399-2413B559-0FE4-48C1-9CF9-D9839F45DA0EQ47705176-FBFFE19C-2BEA-4CF7-AB05-5FECED76C39BQ48177445-EBB27640-6B84-4C49-BC7B-5E373CEEBB8DQ51730904-01816544-EEFD-496C-89C1-6215B840DACDQ53399558-3235456E-0B61-411E-999E-E4AF236490BBQ58556671-BE223FA7-FBD7-437D-8D89-E81FA6147195Q58565497-CD9AB4DD-B853-4AD1-9B42-6DAE45E431EDQ58565572-DDB2E999-11E7-4C10-9051-86C4D80DCD51Q58565595-82E1CCF9-02F1-4A60-83CB-3FDF6417E367
P2860
Long-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Long-term outcomes in hypertro ...... n the cardiac troponin T gene.
@ast
Long-term outcomes in hypertro ...... n the cardiac troponin T gene.
@en
Long-term outcomes in hypertro ...... n the cardiac troponin T gene.
@nl
type
label
Long-term outcomes in hypertro ...... n the cardiac troponin T gene.
@ast
Long-term outcomes in hypertro ...... n the cardiac troponin T gene.
@en
Long-term outcomes in hypertro ...... n the cardiac troponin T gene.
@nl
prefLabel
Long-term outcomes in hypertro ...... n the cardiac troponin T gene.
@ast
Long-term outcomes in hypertro ...... n the cardiac troponin T gene.
@en
Long-term outcomes in hypertro ...... n the cardiac troponin T gene.
@nl
P2093
P50
P1476
Long-term outcomes in hypertro ...... in the cardiac troponin T gene
@en
P2093
Ferdinando Pasquale
Perry Elliott
Petros Syrris
P356
10.1161/CIRCGENETICS.111.959973
P577
2011-12-05T00:00:00Z